Zoetis

What Zoetis does

Zoetis is the world's leading animal health company, founded in 1952 as a division of Pfizer and spun off as an independent publicly traded entity on the New York Stock Exchange (NYSE: ZTS) in 2013. The company develops and commercializes a comprehensive portfolio of veterinary medicines, vaccines, diagnostics, and supporting technologies for both companion animals (cats, dogs, horses) and livestock (cattle, dairy, poultry, sheep, swine), with operations spanning more than 100 countries.

The company's core diagnostic platform is the VETSCAN family of in-clinic instruments, including the VS2 chemistry analyzer (results in 12 minutes from 0.1 ml of blood), the HM5 5-part differential hematology analyzer (22 parameters in under 4 minutes), the i-STAT Alinity v handheld analyzer (2-3 minute results from 2-3 drops of whole blood), the HDmicroscope digital imaging system, the SA sediment analyzer, the UA urine chemistry analyzer, the FUSE PMS connectivity platform, and the VUE WiFi-enabled rapid test reader. These instruments are paired with a proprietary consumables business spanning single-use rotors, multi-species validated test profiles, and a rapid test portfolio covering Lyme disease, Anaplasmosis, Ehrlichiosis, Heartworm, FeLV/FIV, Parvo, Giardia, and canine pancreatic lipase detection. VETSCAN FUSE provides bidirectional integration with veterinary practice management software, embedding Zoetis instruments into clinical workflows.

Zoetis generates revenue primarily through hardware sales and recurring consumables (rotors, cartridges, rapid tests) sold via direct-to-veterinarian channels, a Swiss customer portal (Kundenbereich), and field sales teams. The company serves three primary customer segments: veterinarians and animal health professionals (primary), livestock producers, and pet owners (reached through the zoetispets.com direct-to-consumer portal). The Swiss subsidiary (Zoetis Switzerland, Delémont) provides customer service in German and French. Pricing is not publicly disclosed and is handled via direct quotation. The company was awarded Great Place to Work certification in Switzerland for the fourth consecutive year in 2025.

Name

Zoetis

Legal name

Zoetis Switzerland

Website

https://zoetis.ch

Company type

Public

Founded year

1952

Operating status

Operating

Short description

Zoetis is the world's leading animal health company, providing veterinary medicines, vaccines, diagnostics (VETSCAN platform), and technologies for companion animals and livestock across 100+ countries. It serves veterinarians, livestock producers, and pet owners via field sales, customer portals, and direct-to-consumer channels.

Ownership category

akta.pro rank

Product category

Animal Health Pharmaceuticals and Diagnostics

NAICS

Medical Equipment and Supplies Manufacturing (3391), Biological Product (except Diagnostic) Manufacturing (325414), Veterinary Services (54194)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Biological Products, (No Disgnostic Substances) (2836), Pharmaceutical Preparations (2834), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)

akta.pro primary industry

Laboratory & Point-of-Care Diagnostic Devices (Analyzers, Test Kits, Microscopy) (HLAMAFAI)

akta.pro secondary industries

Veterinary Microbiology & Infectious Disease Testing (Culture/PCR/Serology) (HLAMADAC), Imaging Equipment & Accessories (X-ray, Ultrasound, Endoscopy) (HLAMAFAC), Veterinary Vaccine & Biologics Distributors (HLAMAIAC), Companion Animal Therapeutics (Rx) (HLAMAEAA), Livestock & Production Animal Therapeutics (Rx) (HLAMAEAB), Companion Animal Vaccines (Dogs & Cats) (HLAMAKAA), Veterinary Vaccines (Biologics) (HLAMAEAL)

Keywords

• Veterinary medicines
• Animal health diagnostics
• Veterinary vaccines
• In-clinic diagnostic analyzers
• Livestock health products

Headquarters

HQ city

Delémont

HQ country

Switzerland

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Technology or R&D, Operations, Marketing or Sales, Personnel, Infrastructure

Revenue model

1. Animal Health Products (Medicines, Vaccines, Diagnostics): Zoetis generates revenue through the sale of veterinary medicines, vaccines, diagnostics instruments, and consumable test reagents/rotors/cartridges to veterinarians, livestock producers, and pet owners. The portfolio covers both companion animals (pets) and livestock across species including cattle, dairy, poultry, sheep, swine, horses, cats, and dogs. Direct purchasing is available through the Zoetis customer account portal.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

Core offering

Zoetis develops, manufactures, and sells veterinary medicines, vaccines, diagnostic instruments, and related technologies for companion animals and livestock across more than 100 countries. Its flagship VETSCAN line offers in-clinic diagnostic analyzers (chemistry, hematology, urine, sediment, digital microscopy, handheld blood gas), rapid lateral flow tests, connectivity platforms, and single-use consumable rotors and cartridges. Products are sold primarily to veterinarians, veterinary clinics, and livestock producers, with the Swiss website serving as a regional storefront for direct ordering by registered customers.

Product overview

Zoetis operates as the world's leading animal health company with a comprehensive portfolio of veterinary diagnostic instruments and rapid tests. The VETSCAN family includes multiple integrated diagnostic analyzers: the VS2 chemistry analyzer for blood chemistry and electrolytes, the HM5 hematology analyzer for complete blood counts with 5-part differentiation, the i-STAT Alinity v handheld analyzer for point-of-care blood gases and electrolytes, the HDmicroscope for digital imaging, the SA sediment analyzer for urine microscopy, and the UA urine chemistry analyzer. These instruments are supported by the VETSCAN FUSE connectivity solution for practice management software integration and the VETSCAN VUE rapid test reader. The rapid test portfolio includes individual and combination tests (FLEX4, Heartworm, Anaplasma, Lyme, Ehrlichia, FeLV/FIV, Parvo, Giardia, cPL) for infectious disease detection. All products serve veterinary practices, clinics, and research laboratories across over 100 countries.

Differentiator

Problem solved

Functional benefit

Brands

• VETSCAN: VETSCAN is a comprehensive line of in-house diagnostic equipment for veterinary practices, including chemistry analyzers (VS2), hematology analyzers (HM5), urine analyzers (UA, SA), digital microscopy (HDmicroscope), handheld analyzers (i-STAT Alinity v), rapid tests, and connectivity solutions (FUSE, VUE).
• VETSCAN FUSE
• VETSCAN VUE

Products and services

• VETSCAN VS2 Chemistry Analyzer Benchtop chemistry analyzer delivering laboratory-quality blood chemistry and electrolyte results in 12 minutes using 0.1 ml of whole blood, serum, or plasma, with intelligent quality control (iQC). Used by veterinary clinics for in-clinic diagnostics across companion and large animal species.
• VETSCAN HM5 Hematology Analyzer Fully automated 5-part differential hematology analyzer providing a complete blood count with 22 parameters including cell histograms in under 4 minutes. Validated for 6 species (5-part) and 9 species (3-part). Uses cyanide-free reagents with 6-month shelf life.
• i-STAT Alinity v Handheld Analyzer Portable point-of-care device providing real-time laboratory-quality results from 2-3 drops of whole blood in 2-3 minutes for blood gases, acid-base balance, electrolytes, blood chemistry, and hematology, using multiple cartridge options.
• VETSCAN HDmicroscope Digital Imaging System Multifunctional digital microscope with FPGA dual processors producing uncompressed full 1080p HD video at 60 fps for live viewing, recording, or streaming. Suitable for practice, teaching, and group presentations in veterinary microscopy.
• VETSCAN SA Sediment Analyzer Automated urine sediment analysis system classifying 10 urine components (erythrocytes, leukocytes, rod bacteria, cocci bacteria, squamous and non-squamous epithelial cells, hyaline and non-hyaline casts, calcium oxalate crystals, struvite crystals) with up to 96 images captured per run.
• VETSCAN UA Urine Analyzer Portable urine chemistry analyzer providing 14 semiquantitative urine chemistry parameters including UPC (Urine Protein/Creatinine Ratio) and Mikroalbumin for nephropathy diagnostics and chronic kidney disease staging, in 60 seconds per test strip.
• VETSCAN FUSE Connectivity Solution Bidirectional integration platform connecting VETSCAN diagnostic instruments with veterinary practice management software (PMS) for automated workflow, electronic result capture, integrated patient documentation, and revenue protection from manual billing errors.
• VETSCAN VUE Rapid Test Reader WiFi-enabled rapid test reader platform that automates lateral flow rapid tests via iOS/Android mobile app, with Quick Scan for multiple tests per patient and Timed Scan that automatically evaluates and sends results after 10 minutes.
• VETSCAN Rapid Tests (FLEX4, Heartworm, Anaplasma, Borreliose/Lyme, Ehrlichia, FeLV/FIV, Parvo, Giardia, cPL) Single-use lateral flow rapid tests for in-clinic infectious disease screening in dogs and cats, including a 4-in-1 FLEX4 panel (Lyme, Anaplasmosis, Ehrlichiosis, Heartworm) plus species-specific tests for heartworm, Anaplasma, Borrelia, Ehrlichia, feline leukemia/FIV, parvovirus, Giardia, and canine pancreatic lipase.
• VETSCAN VS2 Test Rotors and Profiles Single-use rotors for the VETSCAN VS2 chemistry analyzer containing diluent and all tests for multi-chemistry blood analysis, including Comprehensive Diagnostic Profile, Preventive Care Profile Plus, Electrolyte Plus, Critical Care Plus, Kidney Profile Plus, Mammalian Liver Profile, Phenobarbital Profile, T4/Cholesterol Profile, Equine Profile Plus, Large Animal Profile, Avian/Reptilian Profile Plus, and Prep Profile II.
• Veterinary Medicines and Vaccines Portfolio Comprehensive portfolio of veterinary medicines and vaccines covering companion animals (cats, dogs, horses) and livestock (cattle, dairy, poultry, sheep, pigs). Includes osteoarthritis treatments referenced in customer-facing materials and a broad pipeline of products developed through global R&D facilities.

Quantifiable outcome

• VETSCAN VS2 delivers results in 12 minutes with 0.1 ml sample volume
• +4 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature8 records

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

Direct peers

• IDEXX Laboratories: IDEXX is the dominant player in companion animal diagnostics, offering in-clinic analyzers (Catalyst, ProCyte, SediVue), reference lab services, and practice management software — directly competing with Zoetis' VETSCAN platform for veterinary clinic wallet share and consumables revenue.
• Elanco Animal Health: Elanco is a global animal health company with overlapping portfolios in livestock and companion animal pharmaceuticals, vaccines, and parasiticides, and competes head-to-head with Zoetis in therapeutic categories across species.
• Boehringer Ingelheim Animal Health: Boehringer Ingelheim's animal health business competes directly with Zoetis in vaccines, parasiticides, and therapeutics for both companion animals and livestock, and is among the top global animal health companies by revenue.
• Virbac: Virbac is a global animal health company offering vaccines, pharmaceuticals, and diagnostics for companion and farm animals, with overlapping product categories and similar distribution through veterinary channels.
• Ceva Santé Animale: Ceva is a privately held global animal health company focused on vaccines, pharmaceuticals, and companion animal products, directly competing with Zoetis in biologics and therapeutics categories worldwide.
• Dechra Pharmaceuticals: Dechra specializes in veterinary pharmaceuticals with a strong focus on companion animal endocrinology, dermatology, and analgesia — categories that overlap with Zoetis' therapeutics portfolio and target the same veterinary prescribing audience.
• Phibro Animal Health: Phibro is a global animal health and nutrition company focused on livestock pharmaceuticals, vaccines, and nutritional specialties, overlapping with Zoetis' production animal portfolio in cattle, poultry, and swine.

Emerging players

• Heska / Antech Diagnostics (Mars Petcare): Acquired by Mars Petcare, Antech Diagnostics and the former Heska provide in-clinic analyzers and reference lab services competing directly with Zoetis' VETSCAN platform, with growing reach through the Mars veterinary clinic footprint.
• Vetsource (formerly Covetrus): Vetsource is a veterinary distribution and services platform offering pharmacy, practice software, and diagnostic-adjacent services, competing with Zoetis' distribution channels and potentially its FUSE practice management integrations.

Broad incumbents

• Eurofins Scientific: Eurofins is a global laboratory services group with veterinary and animal health testing capabilities that overlap with Zoetis' diagnostics portfolio, particularly in infectious disease and food/animal safety testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/Zoetis
• LinkedInlinkedin.com/company/zoetis-schweiz-gmbh

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Zoetis